Department of Pharmaceutical Sciences, School of Pharmacy, University of California Irvine, Irvine, CA 92697, USA.
Department of Computer Science, School of Information and Computer Sciences, University of California Irvine, Irvine, CA 92697, USA.
Cells. 2021 Oct 31;10(11):2967. doi: 10.3390/cells10112967.
G-protein-coupled receptors (GPCRs) play an integral role in the neurobiology of psychiatric disorders. Almost all neurotransmitters involved in psychiatric disorders act through GPCRs, and GPCRs are the most common targets of therapeutic drugs currently used in the treatment of psychiatric disorders. However, the roles of GPCRs in the etiology and pathophysiology of psychiatric disorders are not fully understood. Using publically available datasets, we performed a comprehensive analysis of the transcriptomic signatures of G-protein-linked signaling across the major psychiatric disorders: autism spectrum disorder (ASD), schizophrenia (SCZ), bipolar disorder (BP), and major depressive disorder (MDD). We also used the BrainSpan transcriptomic dataset of the developing human brain to examine whether GPCRs that exhibit chronological age-associated expressions have a higher tendency to be dysregulated in psychiatric disorders than age-independent GPCRs. We found that most GPCR genes were differentially expressed in the four disorders and that the GPCR superfamily as a gene cluster was overrepresented in the four disorders. We also identified a greater amplitude of gene expression changes in GPCRs than other gene families in the four psychiatric disorders. Further, dysregulated GPCRs overlapped across the four psychiatric disorders, with SCZ exhibiting the highest overlap with the three other disorders. Finally, the results revealed a greater tendency of age-associated GPCRs to be dysregulated in ASD than random GPCRs. Our results substantiate the central role of GPCR signaling pathways in the etiology and pathophysiology of psychiatric disorders. Furthermore, our study suggests that common GPCRs' signaling may mediate distinct phenotypic presentations across psychiatric disorders. Consequently, targeting these GPCRs could serve as a common therapeutic strategy to treat specific clinical symptoms across psychiatric disorders.
G 蛋白偶联受体 (GPCRs) 在精神疾病的神经生物学中起着至关重要的作用。几乎所有涉及精神疾病的神经递质都通过 GPCRs 起作用,而 GPCRs 是目前用于治疗精神疾病的治疗药物最常见的靶点。然而,GPCRs 在精神疾病的病因和病理生理学中的作用尚未完全了解。我们使用公开可用的数据集,对主要精神疾病(自闭症谱系障碍 (ASD)、精神分裂症 (SCZ)、双相情感障碍 (BP) 和重度抑郁症 (MDD)) 中的 G 蛋白连接信号的转录组特征进行了全面分析。我们还使用发育中人类大脑的 BrainSpan 转录组数据集,研究了在精神疾病中是否表现出与时间相关表达的 GPCR 比与年龄无关的 GPCR 更有可能失调。我们发现,大多数 GPCR 基因在四种疾病中都存在差异表达,并且 GPCR 超家族作为一个基因簇在四种疾病中都过度表达。我们还发现,在四种精神疾病中,GPCR 的基因表达变化幅度比其他基因家族更大。此外,失调的 GPCR 跨越了四种精神疾病,SCZ 与其他三种疾病的重叠度最高。最后,结果表明,与年龄相关的 GPCR 在 ASD 中失调的趋势大于随机 GPCR。我们的研究结果证实了 GPCR 信号通路在精神疾病的病因和病理生理学中的核心作用。此外,我们的研究表明,常见的 GPCR 信号可能在不同的精神疾病中介导不同的表型表现。因此,针对这些 GPCR 可能是一种治疗跨精神疾病特定临床症状的共同治疗策略。